These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27119370)

  • 21. Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up.
    Ergatoudes C; Thunström E; Hansson PO; Morales D; Mandalenakis Z; Rosengren A; Zhong Y; Caidahl K; Fu M
    J Card Fail; 2018 Sep; 24(9):594-600. PubMed ID: 30048772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure.
    Zhang R; Zhang Y; An T; Guo X; Yin S; Wang Y; Januzzi JL; Cappola TP; Zhang J
    Biomark Med; 2015; 9(5):433-41. PubMed ID: 25985174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty.
    Szadkowska I; Wlazeł RN; Migała M; Szadkowski K; Zielińska M; Paradowski M; Pawlicki L
    Cardiol J; 2013; 20(6):577-82. PubMed ID: 24338533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
    Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
    Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
    Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of galectin-3 in adults with congenital heart disease.
    Baggen VJM; van den Bosch AE; Eindhoven JA; Menting ME; Witsenburg M; Cuypers JAAE; Boersma E; Roos-Hesselink JW
    Heart; 2018 Mar; 104(5):394-400. PubMed ID: 28942393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
    Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    Asleh R; Enriquez-Sarano M; Jaffe AS; Manemann SM; Weston SA; Jiang R; Roger VL
    J Am Coll Cardiol; 2019 May; 73(18):2286-2295. PubMed ID: 31072572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.
    van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; de Boer RA; Asselbergs FW; Wajon EMCJ; Orsel JG; Boersma E; Hillege HL; Akkerhuis KM;
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-3 in Heart Failure: An Update of the Last 3 Years.
    Gehlken C; Suthahar N; Meijers WC; de Boer RA
    Heart Fail Clin; 2018 Jan; 14(1):75-92. PubMed ID: 29153203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multi-biomarker approach for heart failure in patients with hypertension.
    Bielecka-Dabrowa A; Gluba-Brzózka A; Michalska-Kasiczak M; Misztal M; Rysz J; Banach M
    Int J Mol Sci; 2015 May; 16(5):10715-33. PubMed ID: 25984599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study.
    Oikonomou E; Karlis D; Tsalamadris S; Siasos G; Chrysohoou C; Vogiatzi G; Dimitropoulos S; Charalambous G; Kouskouni E; Tousoulis D
    Curr Vasc Pharmacol; 2019; 17(4):396-400. PubMed ID: 29968538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL.
    Oikonomou E; Tsalamandris S; Karlis D; Siasos G; Chrysohoou C; Vogiatzi G; Dimitropoulos S; Charalambous G; Kouskouni E; Tousoulis D
    Biomark Med; 2018 Dec; 12(12):1323-1330. PubMed ID: 30511581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators.
    Francia P; Adduci C; Semprini L; Borro M; Ricotta A; Sensini I; Santini D; Caprinozzi M; Balla C; Simmaco M; Volpe M
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):609-16. PubMed ID: 24400815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-3, a prognostic marker--and a therapeutic target?
    Pereira AR; Menezes Falcão L
    Rev Port Cardiol; 2015 Mar; 34(3):201-8. PubMed ID: 25746675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology.
    Zhang M; Meng Q; Qi X; Han Q; Qi X; Wang F; Du B
    Biomark Med; 2018 Nov; 12(11):1207-1217. PubMed ID: 30499308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.
    Nymo SH; Hulthe J; Ueland T; McMurray J; Wikstrand J; Askevold ET; Yndestad A; Gullestad L; Aukrust P
    Eur J Heart Fail; 2014 Jan; 16(1):68-75. PubMed ID: 23918775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.